Q2 2022

Filed Aug 12, 2022 · 10-Q · 43 days after period end · 0001410578-22-002435

Q2 2022 · 10-Q

Revenue

$4.19M

no prior Q2 2021 on file

Net Income

-$1.81M

no prior Q2 2021 on file

EPS Diluted

-$0.88

no prior Q2 2021 on file

Gross Profit$3,537,296—

Operating Income

Same quarter

no prior Q2 2021 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2022 · filed Aug 12, 2022 · 43 d after period end

Petros Pharmaceuticals, Inc. · CIK 1815903 · Engraved from SEC EDGAR